|
Re: Amarin / Mineral Oil
|
5
|
Resverlogix Corp.
|
Nov 10, 2018 04:20PM
|
|
Re: AHA 2018
|
2
|
Resverlogix Corp.
|
Nov 11, 2018 08:53AM
|
|
Re: AHA 2018
|
5
|
Resverlogix Corp.
|
Nov 11, 2018 10:41AM
|
|
Re: AHA 2018
|
4
|
Resverlogix Corp.
|
Nov 11, 2018 11:46PM
|
|
Re: AHA 2018
|
4
|
Resverlogix Corp.
|
Nov 12, 2018 09:22AM
|
|
Re: AHA 2018
|
3
|
Resverlogix Corp.
|
Nov 12, 2018 11:49AM
|
|
Re: AHA 2018
|
5
|
Resverlogix Corp.
|
Nov 10, 2018 11:04PM
|
|
Re: AHA 2018
|
3
|
Resverlogix Corp.
|
Nov 11, 2018 05:03AM
|
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 12:10PM
|
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 12:18PM
|
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 01:25PM
|
|
Re: Abstract - first example of a "curative" effect?
|
3
|
Resverlogix Corp.
|
Oct 11, 2018 05:42AM
|
|
Re: 3 point MACE vs 5 point MACE
|
2
|
Resverlogix Corp.
|
Nov 02, 2018 06:27PM
|
|
Re: 3 point MACE vs 5 point MACE
|
1
|
Resverlogix Corp.
|
Nov 02, 2018 06:39PM
|
|
Re: 3 point MACE vs 5 point MACE
|
2
|
Resverlogix Corp.
|
Nov 02, 2018 11:06PM
|
|
Re: 3 point MACE vs 5 point MACE
|
5
|
Resverlogix Corp.
|
Nov 03, 2018 04:38AM
|
|
Re: 3 point MACE in Phase 3 should be 10% percent lower than 4 point MACE in Phase 2's
|
4
|
Resverlogix Corp.
|
Nov 06, 2018 10:50AM
|
|
Re: 3 point MACE in Phase 3 should be 10% percent lower than 4 point MACE in Phase 2's
|
3
|
Resverlogix Corp.
|
Nov 06, 2018 11:26AM
|
|
R & D
|
4
|
Resverlogix Corp.
|
Jul 30, 2019 11:12AM
|
|
Publication / Resverlogix An Author
|
3
|
Resverlogix Corp.
|
Aug 20, 2019 10:46AM
|
